{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:08:52Z","timestamp":1792267732877,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Technology Program of Guangdong province, China","award":["NO. 2015A020212018"],"award-info":[{"award-number":["NO. 2015A020212018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12975-018-0634-y","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T10:34:07Z","timestamp":1527071647000},"page":"170-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial"],"prefix":"10.1007","volume":"10","author":[{"given":"Lingna","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinteng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-369X","authenticated-orcid":false,"given":"Yidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"issue":"13","key":"634_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1212\/WNL.0b013e31826959d2","volume":"79","author":"V Misra","year":"2012","unstructured":"Misra V, Ritchie MM, Stone LL, et al. Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology. 2012;79(13):207\u201312.","journal-title":"Neurology"},{"issue":"7","key":"634_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3727\/096368909X470883","volume":"18","author":"M Chopp","year":"2009","unstructured":"Chopp M, Steinberg GK, Kondziolka D, Lu M, Bliss TM, Li Y, et al. Who\u2019s in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant. 2009;18(7):691\u20133.","journal-title":"Cell Transplant"},{"issue":"15","key":"634_CR3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1089\/scd.2013.0089","volume":"22","author":"PH Rosado-de-Castro","year":"2013","unstructured":"Rosado-de-Castro PH, Pimentel-Coelho PM, da Fonseca LM, et al. The rise of cell therapy trials for stroke: review of published and registered studies. Stem Cells Dev. 2013;22(15):2095\u2013111.","journal-title":"Stem Cells Dev"},{"issue":"16","key":"634_CR4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2174\/0929867323666160222113702","volume":"23","author":"ALBA Maria Ferri","year":"2016","unstructured":"Maria Ferri ALBA, Lisini D, Boncoraglio G, et al. Mesenchymal stem cells for ischemic stroke: progresses and possibilities. Curr Med Chem. 2016;23(16):1598\u2013068.","journal-title":"Curr Med Chem"},{"issue":"2","key":"634_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12031-013-0119-0","volume":"52","author":"H Wan","year":"2013","unstructured":"Wan H, Li F, Zhu L, Wang J, Yang Z, Pan Y. Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke. J Mol Neurosci. 2013;52(2):177\u201385.","journal-title":"J Mol Neurosci"},{"issue":"14","key":"634_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000278","volume":"82","author":"QXK Vu","year":"2014","unstructured":"Vu QXK, Eckert M, Zhao W, et al. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology. 2014;82(14):1277\u201386.","journal-title":"Neurology"},{"issue":"6","key":"634_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57(6):874\u201382.","journal-title":"Ann Neurol"},{"issue":"6","key":"634_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010;28(6):1099\u2013106.","journal-title":"Stem Cells"},{"issue":"Pt 6","key":"634_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awr063","volume":"134","author":"O Honmou","year":"2011","unstructured":"Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011;134(Pt 6):1790\u2013807.","journal-title":"Brain"},{"issue":"12","key":"634_CR10","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3727\/096368912X658818","volume":"22","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, Zhu W, Zhu J, Wu L, Xu G, Liu X. Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Cell Transplant. 2013;22(12):2291\u20138.","journal-title":"Cell Transplant"},{"issue":"Suppl 1","key":"634_CR11","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3727\/096368914X684961","volume":"23","author":"LY Qiao","year":"2014","unstructured":"Qiao LY, Huang FJ, Zhao M, et al. A two-year follow-up study of cotransplantation with neural stem\/progenitor cells and mesenchymal stromal cells in ischemic stroke patients. Cell Transplant. 2014;23(Suppl 1):S65\u201372.","journal-title":"Cell Transplant"},{"issue":"7","key":"634_CR12","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","volume":"47","author":"GK Steinberg","year":"2016","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, et al. Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study. Stroke. 2016;47(7):1817\u201324.","journal-title":"Stroke"},{"issue":"1","key":"634_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000333381","volume":"1","author":"A Bhasin","year":"2011","unstructured":"Bhasin A, Srivastava MV, Kumaran SS, et al. Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra. 2011;1(1):93\u2013104.","journal-title":"Cerebrovasc Dis Extra"},{"issue":"1","key":"634_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.46582\/jsrm.1301003","volume":"13","author":"A Bhasin","year":"2017","unstructured":"Bhasin A, Kumaran SS, Bhatia R, Mohanty S, Srivastava MVP. Safety and feasibility of autologous mesenchymal stem cell transplantation in chronic stroke in Indian patients. A four-year follow up. J Stem Cells Regen Med. 2017;13(1):14\u20139.","journal-title":"J Stem Cells Regen Med"},{"issue":"1","key":"634_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3988\/jcn.2016.12.1.14","volume":"12","author":"OY Bang","year":"2016","unstructured":"Bang OY. Clinical trials of adult stem cell therapy in patients with ischemic stroke. J Clin Neurol. 2016;12(1):14\u201320.","journal-title":"J Clin Neurol"},{"key":"634_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/1752-1947-5-562","volume":"5","author":"H Han","year":"2011","unstructured":"Han H, Chang SK, Chang JJ, Hwang SH, Han SH, Chun BH. Intrathecal injection of human umbilical cord blood-derived mesenchymal stem cells for the treatment of basilar artery dissection: a case report. J Med Case Rep. 2011;5:562.","journal-title":"J Med Case Rep"},{"issue":"1\u20132","key":"634_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","volume":"227","author":"B Yamout","year":"2010","unstructured":"Yamout B, Hourani R, Salti H, Barada W, el-Hajj T, al-Kutoubi A, et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol. 2010;227(1\u20132):185\u20139.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"634_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.arcmed.2013.03.007","volume":"44","author":"M Mohyeddin Bonab","year":"2013","unstructured":"Mohyeddin Bonab M, Mohajeri M, Sahraian MA, Yazdanifar M, Aghsaie A, Farazmand A, et al. Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells. Arch Med Res. 2013;44(4):266\u201372.","journal-title":"Arch Med Res"},{"key":"634_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13256-015-0535-6","volume":"9","author":"A Chotivichit","year":"2015","unstructured":"Chotivichit A, Ruangchainikom M, Chiewvit P, Wongkajornsilp A, Sujirattanawimol K. Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report. J Med Case Rep. 2015;9:79.","journal-title":"J Med Case Rep"},{"issue":"2","key":"634_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jcyt.2012.09.005","volume":"15","author":"J Liu","year":"2013","unstructured":"Liu J, Han D, Wang Z, Xue M, Zhu L, Yan H, et al. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy. 2013;15(2):185\u201391.","journal-title":"Cytotherapy"},{"issue":"6","key":"634_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5966\/sctm.2014-0212","volume":"4","author":"KW Oh","year":"2015","unstructured":"Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, et al. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl Med. 2015;4(6):590\u20137.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"634_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.15283\/ijsc.2012.5.1.73","volume":"5","author":"M Andolina","year":"2012","unstructured":"Andolina M. Treatment of spinal muscolar atrophy with intrathecal mesenchymal cells. Int J Stem Cells. 2012;5(1):73\u20135.","journal-title":"Int J Stem Cells"},{"issue":"1","key":"634_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1752-1947-8-87","volume":"8","author":"SW Choi","year":"2014","unstructured":"Choi SW, Park KB, Woo SK, Kang SK, Ra JC. Treatment of progressive supranuclear palsy with autologous adipose tissue-derived mesenchymal stem cells. J Med Case Rep. 2014;8(1):87\u201391.","journal-title":"J Med Case Rep"},{"key":"634_CR24","first-page":"318269","volume":"2015","author":"J Zhu","year":"2015","unstructured":"Zhu J, Xiao Y, Li Z, et al. Efficacy of surgery combined with autologous bone marrow stromal cell transplantation for treatment of intracerebral hemorrhage. Stem Cells Int. 2015;2015:318269.","journal-title":"Stem Cells Int."},{"issue":"8","key":"634_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3109\/14653249.2011.579958","volume":"13","author":"H Dongmei","year":"2011","unstructured":"Dongmei H, Jing L, Mei X, Ling Z, Hongmin Y, Zhidong W, et al. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy. 2011;13(8):913\u20137.","journal-title":"Cytotherapy"},{"key":"634_CR26","first-page":"435093","volume":"2013","author":"L Liu","year":"2013","unstructured":"Liu L, Eckert MA, Riazifar H, et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int. 2013;2013:435093.","journal-title":"Stem Cells Int"},{"key":"634_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pneurobio.2013.11.007","volume":"115","author":"X Liu","year":"2014","unstructured":"Liu X, Ye R, Yan T, Yu SP, Wei L, Xu G, et al. Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol. 2014;115:92\u2013115.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"634_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","volume":"83","author":"PH Lee","year":"2007","unstructured":"Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther. 2007;83(5):723\u201330.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"634_CR29","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/STROKEAHA.107.502047","volume":"35","author":"P Walczak","year":"2008","unstructured":"Walczak P, Zhang J, Gilad AA, et al. Dual-modality monitoring of targeted intra-arterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;35(9):1569\u201374.","journal-title":"Stroke"},{"issue":"2","key":"634_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/STROKEAHA.108.526863","volume":"40","author":"L Wechsler","year":"2009","unstructured":"Wechsler L, Steindler D, Borlongan D, et al. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40(2):510\u20135.","journal-title":"Stroke"},{"key":"634_CR31","first-page":"732","volume":"36","author":"TJ Kean","year":"2013","unstructured":"Kean TJ, Lin P, Caplan AI, et al. MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int. 2013;36:732\u201342.","journal-title":"Stem Cells Int"},{"issue":"1","key":"634_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.jcbfm.9600311","volume":"27","author":"LH Shen","year":"2007","unstructured":"Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab. 2007;27(1):6\u201313.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"17","key":"634_CR33","first-page":"155","volume":"6","author":"J Boltze","year":"2015","unstructured":"Boltze J. The dark side of the force\u2014constraints and complications of cell therapies for stroke. Front Neurol. 2015;6(17):155.","journal-title":"Front Neurol"},{"issue":"2","key":"634_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/STROKEAHA.113.003379","volume":"45","author":"SI Savitz","year":"2014","unstructured":"Savitz SI, Cramer SC, Wechsler L, Consortium S. Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke. 2014;45(2):634\u20139.","journal-title":"Stroke"},{"issue":"4","key":"634_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","volume":"2","author":"P Bianco","year":"2008","unstructured":"Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2(4):313\u20139.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"634_CR36","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"J Seok","year":"2013","unstructured":"Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013;110(9):3507\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"634_CR37","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1073\/pnas.1401965111","volume":"112","author":"K Takao","year":"2015","unstructured":"Takao K, Miyakawa T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2015;112(4):1167\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"634_CR38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(3):870\u2013947.","journal-title":"Stroke"},{"issue":"1","key":"634_CR39","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar3257","volume":"13","author":"Y Wu","year":"2011","unstructured":"Wu Y, Ren M, Yang R, Liang X, Ma Y, Tang Y, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th\/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 2011;13(1):R29.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"634_CR40","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3727\/096368913X667727","volume":"23","author":"P Wang","year":"2014","unstructured":"Wang P, Li Y, Huang L, Yang J, Yang R, Deng W, et al. Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial. Cell Transplant. 2014;23(10):1293\u2013303.","journal-title":"Cell Transplant"},{"issue":"12","key":"634_CR41","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","volume":"45","author":"K Prasad","year":"2014","unstructured":"Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke. Stroke. 2014;45(12):3618\u201324.","journal-title":"Stroke"},{"issue":"6","key":"634_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2165\/00019053-200725060-00002","volume":"25","author":"SD Walter","year":"2007","unstructured":"Walter SD, Gafni A, Birch S. Estimation, power and sample size calculations for stochastic cost and effectiveness analysis. PharmacoEconomics. 2007;25(6):455\u201366.","journal-title":"PharmacoEconomics"},{"issue":"11","key":"634_CR43","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1161\/STROKEAHA.107.488536","volume":"38","author":"JL Saver","year":"2007","unstructured":"Saver JL. Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke. 2007;38(11):3055\u201362.","journal-title":"Stroke"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-018-0634-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T04:38:02Z","timestamp":1604291882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-018-0634-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1007\/s12975-018-0634-y","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"20 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Adverse events and compliance to protocol will be monitored by an independent data monitoring committee, with in-person monitoring visits and phone contacts. The study protocol and information consent forms have been approved by the Ethical Committee of the Sun Yat-sen Memorial Hospital, Sun Yat-sen University. The trial has been registered in the Chinese Clinical Trial Registry (registration number: ChiCTR-INR-16008908; date of approval 25 July 2016). And all patients will be informed verbally and provided with a written document about the study by the investigators.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}